Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPCAT II: Aspirin vs Rivaroxaban for Extended VTE Prophylaxis
NCT01720108Phase 3Completed
- Start
- Feb 2013
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in venous thromboembolism (VTE). Started Feb 2013; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01720108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720108.